Boehringer invests $50M in Puerto Rico facilityNovember 25, 2019Boehringer Ingelheim has expanded the production capacity of its manufacturing site in Barceloneta, P.R., with a $50-million investment.
Education Center - SponsoredLowering radiation exposure in your veterinary practiceby • IDEXX LaboratoriesRadiography is vital to the best practice of veterinary medicine because it enables the understanding and diagnosis of—and informs the treatment of—a variety of health issues.
FDA approves NexGard expanded label claimsAugust 22, 2018Merial, part of Boehringer Ingelheim, received approval from the U.S Food and Drug Administration to expand the label claims for NexGard (afoxolaner). The flea and tick control product is now approved to prevent Borrelia burgdorferi infections as a direct result of it killing Ixodes scapularis vector ticks, commonly called black-legged, or deer, ticks. NexGard is the first and only flea and tick product to receive FDA approval for preventing infections that cause Lyme disease …
